Development and application of a colloidal-gold immunochromatographic strip for detecting Getah virus antibodies

Zhiwen Jiang,Ying Qin,Letian Zhang,Gang Xing,Zhiyu Shi,Wanjie Song,Georgi M. Dobrikov,Jie Chen,Shuo Su
DOI: https://doi.org/10.1007/s00253-024-13168-5
IF: 5
2024-06-02
Applied Microbiology and Biotechnology
Abstract:Getah virus (GETV) is a re-emerging mosquito-borne alphavirus that is highly pathogenic, mainly to pigs and horses. There are no vaccines or treatments available for GETV in swine in China. Therefore, the development of a simple, rapid, specific, and sensitive serological assay for GETV antibodies is essential for the prevention and control of GETV. Current antibody monitoring methods are time-consuming, expensive, and dependent on specialized instrumentation, and these features are not conducive to rapid detection in clinical samples. To address these problem, we developed immunochromatographic test strips (ICTS) using eukaryotically expressed soluble recombinant p62-E1 protein of GETV as a labelled antigen, which has good detection sensitivity and no cross-reactivity with other common porcine virus-positive sera. The ICTS is highly compatible with IFA and ELISA and can be stored for 1 month at 37 °C and for at least 3 months at room temperature. Hence, p62-E1-based ICTS is a rapid, accurate, and convenient method for rapid on-site detection of GETV antibodies.
biotechnology & applied microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a simple, rapid, specific and sensitive serological detection method for detecting Getah virus (GETV) antibodies. Specifically, in view of the current lack of effective GETV vaccines and treatment methods in China, the authors have developed a technology based on the colloidal gold immunochromatographic test strip (ICTS), using the expressed soluble recombinant p62 - E1 protein as a labeled antigen to achieve rapid on - site detection of GETV antibodies. This method aims to overcome the shortcomings of existing antibody monitoring methods, such as being time - consuming, costly and relying on special instruments, so as to achieve rapid detection in clinical samples, which is helpful for the prevention and control of GETV.